you are in demo mode.    to view your own genetic profile, order your scan now.

Site search

  • your results
  • background
  • risk and prevention
  • scientific details
  • research
  • discussion
  • >>

Recent changes:
Jan 12 2010, 08:40 AM Added two risk variants for Europeans

Atrial Fibrillation

Atrial fibrillation (AF) is the most common sustained heart rhythm abnormality in man.

Please select a gender or population for your results.

This disease has different risk results depending on population or gender. Below you can select the ones you belong to.

Ethnicity: 

Gender:   

Results can vary according to population and/or gender. Results currently based on:

European ancestry

Trait_world_map

change

Male

Trait_male_female

change


Af
According to the selected literature, the relative genetic risk calculated from your genotype for males of European ancestry is 0.95. This corresponds to a 23.9% lifetime risk of developing atrial fibrillation, which is 5% less than for males of European ancestry in general (source) . Note that these calculations may not include all risk factors.
The lifetime risk of your type
It is estimated that 24 of every 100 males of European ancestry with your genotype variants develop this disease in their lifetime.
Af
The average lifetime risk
On average, about 25 of every 100 males of European ancestry develop this disease in their lifetime.
Af

Consult with our experts

Need something clarified? If so, please feel free to contact our experts. Based on the nature of your questions, we may refer you to a genetic counselor.

ask a question about Atrial Fibrillation

Keep in mind

These are the results of calculations comparing your genetic sequence to sequence of participants in studies published in the world literature on genetic risk for this disease. Read more about how deCODEme calculates risks.

This test was developed and its performance characteristics determined by the deCODE genetics Diagnostic Laboratory. It has not been cleared or approved by the U. S. Food and Drug Administration (FDA).